Login

FIRST Shares Norway, positions | Erik Haugland, CEO, First Fondene ASAS OF 30 JUN 2023 00:10:00

Share On Facebook Share On Twitter

Erik Haugland is the CEO of First Fondene AS

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Market Sell-Off Driven by Valuation Concerns and Election Uncertainty
00:10:00
Mirriad Advertising CEO Stephan Beringer discusses the company's half-year results with Proactive.
00:10:00
Lithium Chile's High Flow Rates and Resource Expansion in the Lithium Triangle
00:10:00
Bradesco's Digital Evolution: Pioneering Tech Integration for Enhanced Customer Experience | Marcelo Noronha, CEO, Banco Bradesco S.A.
00:10:00
Brett Harriss, analyst and associate portfolio manager at G Research, discusses hesitancy in investing in streaming on "Power Lunch."
00:10:00
Wall Street Connected: Callon Petroleum | Joseph C Gatto Jr, CEO, Callon Petroleum CoCPE:NYQ
00:00:00
Clive Dix BSc PhD HonFBPhS, CEO, C4X Discovery Holdings PLC
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:10:00
Boryszew's Strong Performance and Future Plans | Wojciech Kowalczyk - CEO of Boryszew Group.
00:10:00
The Vital Role of Non-Executive Directors in Today's Business Landscape | Steven Fine, CEO, Peel Hunt Ltd.
00:10:00
Todd River Resources' Q1 Update: Drilling, Surveying, and Upcoming Catalysts
00:10:00
Mastering Visitor Management: A Comprehensive Tutorial on Datawatch's Visitor Management System | William F. Peel, VP of Datawatch Corp

© 2017 - Neuhu+